Thyroid Dysfunction: Reproduction and Postpartum Thyroiditis

ABSTRACT

Thyroid function during pregnancy is characterized by changes in circulating thyroid hormone concentrations related to alterations in thyroxine binding globulin (TBG), human chorionic gonadotropin (hCG), and iodine status. The immunology of normal pregnancy shows a reduction in antibody titer during gestation and an increase in T helper-2 (TH2) immune responses. Thyroid dysfunction may cause menstrual disturbances in hyper- and hypothyroidism but less marked disturbances of sexual function in men. Fertility is reduced in hypo- and hyperthyroid females. Accumulating evidence suggests a strong association between the presence of thyroid antibodies and fetal loss, although the data relating to recurrent abortion are not so convincing. Asymptomatic maternal gestational hypothyroidism may occur in up to 2.5% of women; studies have shown a significant impact of this condition in causing a decrease of child IQ, suggesting that screening for maternal hypothyroidism with intervention may be justified. Postpartum thyroid disease occurs in 5 to 9% of women and thyroid dysfunction postpartum is seen in 50% of thyroid peroxidase antibody positive (TPO Ab+ve) women. There is a significant rate of hypothyroidism in long-term follow-up of women who have transient postpartum thyroid dysfunction.

KEYWORD

Pregnancy - antibodies - postpartum - immunology - thyroid

REFERENCES

• 1 Chin W W, Yen P M. Molecular mechanisms of nuclear thyroid hormone action. In: Braverman LE, ed. Diseases of the Thyroid Totowa, NJ: Humana Press 1997: 1-15
• 2 Weetman A P, McGregor A M. Autoimmune thyroid disease: further developments in our understanding.  Endocr Rev . 1994;  15 788-830
• 3 Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology.  Endocr Rev . 1997;  18 871-887
• 4 World Health Organization (WHO), United Nations Children's Fund (UNICEF), International Council for Control of Iodine Deficiency Disorders (ICCIDD) 1999. Progress towards the elimination of iodine deficiency disorders (IDD). WHO booklet, pp. 1-33
• 5 Brent G A. Maternal thyroid function: interpretation of thyroid function tests in pregnancy.  Clin Obstet Gynecol . 1997;  40 3-15
• 6 Weetman A P. The immmunology of pregnancy.  Thyroid . 1999;  9 643-646
• 7 Ludgate M, Jasani B. Apoptosis in autoimmune and non-autoimmune thyroid disease.  J Pathol . 1997;  182 123-124
• 8 Russell A S. Biology of human pregnancy: immune modulation (TH1 and TH2 responses in pregnancy).  Scand J Rheumatol . 1998;  27 14-17
• 9 Pepe G J, Albrecht E D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy.  Endocr Rev . 1995;  16 608-648
• 10 Davies T F. The thyroid immunology of the postpatum period.  Thyroid . 1999;  9 675-684
• 11 Elenkov I J, Wilder R L, Bakalov V K. IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times.  J Clin Endocrinol Metab . 2001;  86 4933-4938
• 12 Longcope C. The male and female reproductive systems in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text Philadelphia: Lippincott Williams & Wilkins 2000: 652-658
• 13 Krassas G E, Pontikides N, Kaltsas T. Disturbances of menstruation in hypothyroidism.  Clin Endocrinol . 1999;  50 655-659
• 14 Jannini E A, Ulisse S, D'Armiento M. Thyroid hormone and male gonadal function.  Endocr Rev . 1995;  16 443-459
• 15 Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story.  Thyroid . 2001;  11 57-63
• 16 Stagnaro-Green A S, Roman S H, Cobin R H, El-Harazy E, Alvarez-Marfany M, Davies T. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies.  JAMA . 1990;  264 1422-1425
• 17 Glinoer D, Fernandez-Soto M, Bourdoux P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions.  J Clin Endocrinol Metab . 1991;  73 421-427
• 18 Lejeune B, Grun J P, deNayer P, Servais G, Glinoer D. Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension.  Br J Obstet Gynecol . 1993;  100 669-672
• 19 Singh A, Dantas Z N, Stone S, Asch R. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies.  Fertil Steril . 1995;  63 277-281
• 20 Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y. Effects of autoantibodies of the course of pregnancy and fetal growth.  Obstet Gynecol . 1997;  90 364-369
• 21 Imaizumi M, Prisker A, Unger P, Davies T F. Intrathyroidal fetal microchimerism in pregnancy and post partum.  Endocrinology . 2002;  143 247-253
• 22 Srivatsa B, Srivatsa S, Johnson K L, Samura O, Lee S L, Bianchi D W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study.  Lancet . 2001;  358 2034-2038
• 23 Nelson J L. Michrochimerism: expanding new horizon in human health or incidental remnant of pregnancy?.  Lancet . 2001;  358 2011-2012
• 24 Morreale de Escobar G, Obregón M J, Escobar del R ey. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?.  J Clin Endocrinol Metab . 2000;  85 3975-3987
• 25 Haddow J E, Palomaki G E, Allan W C. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.  N Engl J Med . 1999;  341 549-555
• 26 Pop V J, Kuijpens J L, van Baar L A. Low maternal free thyroxine concentrations during early pergnancy are associated with impaired psychomotor development in infancy.  Clin Endocrinol . 1999;  50 149-155
• 27 Pop V J, de Vries E, van Baar L A. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development?.  J Clin Endocrinol Metab . 1995;  80 3561-3566
• 28 Mandel S J, Reed Larsen P, Seeley E W, Brent G A. Increased need for thyroxine during pregnancy in women with primary hypothyroidism.  N Engl J Med . 1990;  323 91-96
• 29 Gonzalez-Jimenez A, Fernandez-Soto M L, Escobar-Jimenez F, Glinoer D, Navarrete L. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.  Thyroidology . 1993;  5 13-20
• 30 Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organised by the European Thyroid Association.  Eur J Endocrinol . 1998;  139 584-590
• 31 Lazarus J H, Hall R, Othman S. The clinical spectrum of postpartum thyroid disease.  Q J Med . 1996;  89 429-435
• 32 Lazarus J H, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change.  Clin Endocrinol . 2000;  53 265-278
• 33 Muller A F, Drexhage H A, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care.  Endocr Rev . 2001;  22 605-630
• 34 Harris B, Othman S, Davies J. Association between postpartum thyroid dysfunction and thyroid antibodies and depression.  BMJ . 1991;  305 152-156
• 35 Adams H, Jones M C, Othman S. The sonographic appearances in postpartum thyroiditis.  Clin Radiol . 1992;  45 311-318
• 36 Creagh F M, Parkes A B, Lee A. The iodide perchlorate discharge test in women with previous post-partum thyroiditis: relationship to sonographic appearance and thyroid function.  Clin Endocrinol . 1994;  40 765-768
• 37 Stagnaro-Green A, Roman H, Cobin R H, El-Harazy E, Wallenstain S, Davies T F. Prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction.  J Clin Endocrinol Metab . 1992;  74 645-653
• 38 Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T. Pregnancy and murine thyroiditis: thyroglobulism immunization leads to fetal loss in specific allogenetic pregnancies.  Endocrinology . 2001;  142 823-829
• 39 Premawardhana L D, Parkes A B, Ammari F. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity.  J Clin Endocrinol Metab . 2000;  85 71-75
• 40 Lazarus J H, Ludgate M E. Prevention and treatment of postpartum Graves' disease. In: Davies TF, ed. Baillière's Clinical Endocrinology and Metabolism London: WB Saunders 1997: 549-560